Literature DB >> 12900342

Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair.

Arnt E Fiane1, Vibeke Videm, Per S Lingaas, Lars Heggelund, Erik W Nielsen, Odd R Geiran, Michael Fung, Tom E Mollnes.   

Abstract

BACKGROUND: Complement activation contributes to ischemia-reperfusion injury. Patients undergoing thoracoabdominal aortic aneurysm (TAAA) repair suffer extensive ischemia-reperfusion and considerable systemic inflammation. METHODS AND
RESULTS: The degree and mechanism of complement activation and its role in inflammation were investigated in 19 patients undergoing TAAA repair. Patients undergoing open infrarenal aortic surgery (n=5) or endovascular descending aortic aneurysm repair (n=6) served as control subjects. Substantial complement activation was seen in TAAA patients but not in controls. C1rs-C1-inhibitor complexes increased moderately, whereas C4bc, C3bBbP, C3bc, and the terminal SC5b-9 complex (TCC) increased markedly after reperfusion, reaching a maximum 8 hours after reperfusion. Interleukin (IL)-1beta, tumor necrosis factor alpha (TNF-alpha), and IL-8 increased significantly in TAAA patients but not in controls, peaking at 24 hours postoperatively and correlating closely with the degree of complement activation. IL-6 and IL-10 increased to a maximum 8 hours after reperfusion in the TAAA patients, were not correlated with complement activation, and increased moderately in the control subjects. Myeloperoxidase and lactoferrin increased markedly before reperfusion in all groups, whereas sICAM-1, sP-selectin, and sE-selectin were unchanged. No increase was observed in complement activation products, IL-1beta, TNF-alpha, or IL-8 in a mannose-binding lectin (MBL)-deficient TAAA patient, whereas IL-6, IL-10, myeloperoxidase, and lactoferrin increased as in the controls. Two other MBL-deficient TAAA patients receiving plasma attained significant MBL levels and showed complement and cytokine patterns identical to the MBL-sufficient TAAA patients.
CONCLUSIONS: The data suggest that complement activation during TAAA repair is MBL mediated, amplified through the alternative pathway, and responsible in part for the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900342     DOI: 10.1161/01.CIR.0000084550.16565.01

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  31 in total

1.  Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions.

Authors:  M Harboe; P Garred; M S Borgen; G L Stahl; A Roos; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

2.  Impact of serum high-mobility group box 1 protein elevation on oxygenation impairment after thoracic aortic aneurysm repair.

Authors:  Takashi Kohno; Toshihisa Anzai; Hideyuki Shimizu; Hidehiro Kaneko; Yasuo Sugano; Shingo Yamada; Tsutomu Yoshikawa; Akitoshi Ishizaka; Ryohei Yozu; Satoshi Ogawa
Journal:  Heart Vessels       Date:  2010-10-30       Impact factor: 2.037

3.  Elevated Serum Mannose-Binding Lectin Levels Are Associated with Poor Outcome After Acute Ischemic Stroke in Patients with Type 2 Diabetes.

Authors:  Fang-Yu Song; Meng-Hai Wu; Li-Hua Zhu; Zhi-Qiang Zhang; Qin-De Qi; Chang-Li Lou
Journal:  Mol Neurobiol       Date:  2014-10-25       Impact factor: 5.590

4.  The mannose-binding lectin pathway is a significant contributor to reperfusion injury in the type 2 diabetic heart.

Authors:  Laura R La Bonte; Betsy Dokken; Grace Davis-Gorman; Gregory L Stahl; Paul F McDonagh
Journal:  Diab Vasc Dis Res       Date:  2009-07       Impact factor: 3.291

Review 5.  Phagocyte-myocyte interactions and consequences during hypoxic wound healing.

Authors:  Shuang Zhang; Shirley Dehn; Matthew DeBerge; Ki-Jong Rhee; Barry Hudson; Edward B Thorp
Journal:  Cell Immunol       Date:  2014-05-02       Impact factor: 4.868

6.  Complement regulator CD59 protects against angiotensin II-induced abdominal aortic aneurysms in mice.

Authors:  Gongxiong Wu; Ting Chen; Aliakbar Shahsafaei; Weiguo Hu; Roderick T Bronson; Guo-Ping Shi; Jose A Halperin; Huseyin Aktas; Xuebin Qin
Journal:  Circulation       Date:  2010-03-08       Impact factor: 29.690

7.  APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.

Authors:  Danielle G Souza; Dirk Esser; Roberta Bradford; Angélica T Vieira; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

8.  Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1.

Authors:  Gu Gong; Li-bang Yuan; Ling Hu; Wei Wu; Liang Yin; Jing-li Hou; Ying-hai Liu; Le-shun Zhou
Journal:  Acta Pharmacol Sin       Date:  2011-12-12       Impact factor: 6.150

9.  Systemic complement activation following human acute ischaemic stroke.

Authors:  E D Pedersen; U Waje-Andreassen; C A Vedeler; G Aamodt; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

10.  Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice.

Authors:  Sofia Xanthoulea; Melanie Thelen; Chantal Pöttgens; Marion J J Gijbels; Esther Lutgens; Menno P J de Winther
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.